The Journal of Medical Microbiology, Vol 43, Issue 5 318-327, Copyright © 1995 by Society for General Microbiology

JOURNAL ARTICLE

Staphylococcal scalded skin syndrome

C. G. Gemmell
Department of Bacteriology, University of Glasgow Medical School, Glasgow Royal Infirmary, University NHS Trust.

Staphylococcal scalded skin syndrome (SSSS) is a recognised clinical entity that affects primarily the very young and, in rare cases, the very old or the immunocompromised. Koch's postulates have been fulfilled in that: (i) Staphylococcus aureus is isolated from every case; (ii) S. aureus can reproduce the syndrome in an experimental animal model; (iii) a specific extracellular toxin can reproduce the syndrome; and (iv) antibody to the toxin can protect experimental animals. Although exfoliative toxin (ET) is responsible for the skin loosening seen in SSSS, it does not account for all the symptoms of the disease. Purified ET does not cause erythema in either neonatal mice or man, and the lesions are not painful unless the loosened epidermis is removed. This suggests that other factors, e.g., delta-haemolysin, are involved in the pathogenesis of this condition. Although much has been learned about the pathogenesis of the syndrome, we are still largely ignorant of the factors which govern host resistance to SSSS (i.e., intoxication by ET-producing strains of S. aureus). It is fortunate from the patient's point of view that the aetiological agent can be destroyed readily by the use of appropriate antibiotic therapy.

This article has been cited by other articles:

				O. Yamasaki, T. Yamaguchi, M. Sugai, C. Chapuis-Cellier, F. Arnaud, F. Vandenesch, J. Etienne, and G. Lina Clinical Manifestations of Staphylococcal Scalded-Skin Syndrome Depend on Serotypes of Exfoliative Toxins J. Clin. Microbiol., April 1, 2005; 43(4): 1890 - 1893. [Abstract] [Full Text] [PDF]

				R. Filipek, M. Rzychon, A. Oleksy, M. Gruca, A. Dubin, J. Potempa, and M. Bochtler The Staphostatin-Staphopain Complex: A FORWARD BINDING INHIBITOR IN COMPLEX WITH ITS TARGET CYSTEINE PROTEASE J. Biol. Chem., October 17, 2003; 278(42): 40959 - 40966. [Abstract] [Full Text] [PDF]

				K. Becker, A. W. Friedrich, G. Lubritz, M. Weilert, G. Peters, and C. von Eiff Prevalence of Genes Encoding Pyrogenic Toxin Superantigens and Exfoliative Toxins among Strains of Staphylococcus aureus Isolated from Blood and Nasal Specimens J. Clin. Microbiol., April 1, 2003; 41(4): 1434 - 1439. [Abstract] [Full Text] [PDF]

				D. A Alkurtass and A. S Al-Jazairi Possible Captopril-Induced Toxic Epidermal Necrolysis Ann. Pharmacother., March 1, 2003; 37(3): 380 - 383. [Abstract] [Full Text] [PDF]

				A. Gravet, P. Couppie, O. Meunier, E. Clyti, B. Moreau, R. Pradinaud, H. Monteil, and G. Prevost Staphylococcus aureus Isolated in Cases of Impetigo Produces Both Epidermolysin A or B and LukE-LukD in 78% of 131 Retrospective and Prospective Cases J. Clin. Microbiol., December 1, 2001; 39(12): 4349 - 4356. [Abstract] [Full Text] [PDF]

				L. R. W. Plano, B. Adkins, M. Woischnik, R. Ewing, and C. M. Collins Toxin Levels in Serum Correlate with the Development of Staphylococcal Scalded Skin Syndrome in a Murine Model Infect. Immun., August 1, 2001; 69(8): 5193 - 5197. [Abstract] [Full Text] [PDF]

				S. Ladhani, C. L. Joannou, D. P. Lochrie, R. W. Evans, and S. M. Poston Clinical, Microbial, and Biochemical Aspects of the Exfoliative Toxins Causing Staphylococcal Scalded-Skin Syndrome Clin. Microbiol. Rev., April 1, 1999; 12(2): 224 - 242. [Abstract] [Full Text] [PDF]

				B. Peters, J. Hentschel, H. Mau, E. Halle, W. Witte, and M. Obladen Staphylococcal Scalded-Skin Syndrome Complicating Wound Infection in a Preterm Infant with Postoperative Chylothorax J. Clin. Microbiol., October 1, 1998; 36(10): 3057 - 3059. [Abstract] [Full Text]

				S. Ladhani and R. W Evans Staphylococcal scalded skin syndrome Arch. Dis. Child., January 1, 1998; 78(1): 85 - 88. [Full Text]